By Editorial Team 
A recent survey found only 12% of independent creators feel like they have a seat at the table in regulatory talks, which points to a huge gap between the people making new things and the policymakers in D.C. This statistic is a clear signal that current advocacy isn’t working, especially when it comes to the FDA’s public meeting process. So how can indie creators actually get their voices heard and fix this disconnect?
Key Takeaways
- Submitting written comments is a direct way to influence FDA policy, but less than 5% of indie creators actually did it in 2023.
- Targeted digital campaigns work. Trade associations saw a 30% jump in creators asking for regulatory help after running them.
- Technical details matter, as 18% of creator comments get rejected each year for simple formatting mistakes on the FDA’s submission portals.
- Collective action on platforms like Change.org or private forums gets attention, with some campaigns pulling in over 50,000 signatures to amplify creator issues.
“Over 30% of Gen Zers find information through chatbots or AI, and 47% of today’s marketers use AI for research, according to HubSpot’s AI Trends for Marketers report.”
The 12% Representation Gap: A Call to Action
That 12% of independent creators feel represented in regulatory talks isn’t just a statistic from the 2025 Creator Economy Report by HubSpot Research. It’s a symptom of a systemic problem. From my experience with emerging brands, this feeling comes from a belief that regulatory bodies are impossible to penetrate or that one person can’t make a difference. We have to correct this misconception. The FDA, like a lot of agencies, actually runs on public input, but its methods for getting that input aren’t always clear to small businesses or solo innovators who are already swamped.
The gap stems from a lack of effective, targeted strategies for creators to get involved, not from the FDA being unwilling to listen. Think about it: you’re developing a product, building a marketing plan, and working through compliance. The idea of also having to learn federal regulatory comment procedures on top of all that feels like too much. But if you don’t engage, policies get written by people who don’t understand the real-world impact on the very entrepreneurs driving market innovation.
Less Than 5% of Indie Creators Submit Written Comments
Here’s a shocking number from the 2024 IAB Digital Ad Ecosystem report: less than 5% of independent creators submitted written comments to the FDA in 2023, even on topics directly affecting them. This is a massive missed opportunity. Written comments are a powerful tool because they become part of the official public record that agency staff are required to review. Such a low number tells me creators either don’t know this is an option, don’t get why it’s important, or don’t have the tools to write a good submission.
When I advise startups, I hammer this point home: you have to understand the regulatory game from day one. Thinking your amazing product will just find its way to market is naive. The FDA’s process is there to ensure safety and efficacy, and for anyone in supplements, cosmetics, or wellness, engaging with it is foundational for growth. A well-written comment isn’t just complaining. It’s about contributing to a more informed regulatory environment by providing real-world data, pointing out challenges for small businesses, or suggesting different compliance methods the agency hasn’t considered.
We need to see the FDA process as a dialogue, not a hurdle. To do that, creators need more than just awareness. They need practical guides, templates, and maybe even shared platforms that make the submission process less of a headache.
18% of Submissions Rejected Due to Formatting Errors
A frustrating and often overlooked problem is the technical side of things. According to the FDA’s own public comment portal stats for 2023, around 18% of all public comments were rejected because of formatting errors or for not following submission guidelines. That’s a huge amount of wasted effort, and it points to a disconnect between the agency’s requirements and a normal person’s ability to meet them.
This isn’t happening because creators are sloppy. It’s happening because submission interfaces can be clunky and the instructions unclear. For instance, an agency might demand a specific file type like PDF/A, have strict character limits, or require a specific docket number in the subject line, and if you miss one of those small details, your comment gets automatically kicked out without ever being read. I always tell my clients to go over the technical specs on the submission portal days before the deadline. Don’t wait. The Regulations.gov platform is powerful, but it has its quirks. This problem shows we need more intuitive interfaces or at least clearer guidance written for individuals, not just for big companies with entire regulatory departments.
Trade Associations See 30% Increase in Creator Inquiries
Here’s some good news. A recent eMarketer analysis found that trade associations saw a 30% increase in inquiries from creators asking for help with regulations after running targeted digital outreach in late 2024. These campaigns often included webinars with practical titles like “Working through FDA Regulations for Small Businesses” or “Your Voice in Policy: How to Submit a Public Comment.”
That 30% jump proves that when you make this information accessible and relevant, creators will absolutely engage. Organizations like the Natural Products Association or the Personal Care Products Council have staff who do nothing but watch the FDA and translate dense rules into actionable advice. They also organize collective comments that give individual voices more weight. For an independent creator in a regulated field, I strongly believe joining one of these groups is a smart investment. You get both compliance help and a real chance to shape your industry’s future.
The Conventional Wisdom: “It’s Too Difficult for Individuals”
There’s a common belief that trying to influence a body like the FDA is impossible for a small business or one person. I hear it all the time: “It’s too hard,” “They only listen to big companies,” “My voice doesn’t matter.” I completely disagree. Yes, large corporations have their lobbying teams, but the whole point of the public comment system is to get input from everyone, including individuals. The difficulty often comes from a lack of good guidance and resources, not from a bias against small players.
Think about a small-batch cosmetic maker who develops a new, sustainable ingredient. Without their input, the FDA might write a rule based on large-scale manufacturing that would kill that kind of innovation before it starts. That creator’s specific perspective, sent in as a researched comment, can show why flexible rules are needed. And the power of many individual comments, even short ones, adds up quickly to show widespread support or concern. The path requires work, but ignoring it means giving up your influence entirely. Engaging with these processes, particularly an FDA public meeting, is a component of building a fair market for independent creators. By understanding how to provide input, using collective advocacy, and just following the submission guidelines, creators can go from being spectators to being active players in shaping their own industries.
What is an FDA public meeting?
It’s a formal meeting where the U.S. Food and Drug Administration asks for input on things like new regulations or policies from industry, consumers, and the public. They usually have presentations from FDA staff and let people give verbal or written comments.
How can independent creators find out about upcoming FDA public meetings?
You can find them by regularly checking the Federal Register website and the FDA’s own public meetings page. A good shortcut is to subscribe to newsletters from the FDA and any relevant trade associations, which send out timely alerts.
What is the most effective way for an individual creator to submit comments to the FDA?
The best way is to use the Regulations.gov portal, which is the government’s official system. To be effective, make sure your comment is well-researched, clearly states your point of view, and includes the specific docket number for the rule or meeting you’re commenting on.
Are there resources available to help independent creators understand FDA regulations?
Yes, several. The FDA itself offers guidance documents and small business assistance on its website. Trade associations are also a great resource, as they often publish easy-to-understand summaries and host workshops to help creators figure out FDA requirements.
Can joining a trade association help with FDA advocacy?
Absolutely. Joining a good trade association can seriously boost an independent creator’s advocacy. These groups have staff who are experts, they give you direct guidance, and they submit consolidated comments that represent their entire membership, which gives your collective voice much more impact.
